Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study by Ruby S. Gibson, MD, Corey L. Snyder, BSA, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis by Charlotte Greif, MD, Ruby S. Gibson, MD, Alexa B. Kimball, MD, MPH, Zachary E. Holcomb, MD, Martina L. Porter, MD

Connect to this object online.

Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review by Corey L. Snyder, MD, Ruby S. Gibson, MD, Stella X. Chen, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.